Month: November 2021

FDA Panel Backs First-of-a-Kind COVID-19 Pill From Merck

A panel of U.S. health advisers on Tuesday narrowly backed a closely watched COVID-19 pill from Merck, setting the stage for a likely authorization of the first drug that Americans could take at home to treat the coronavirus. 

A Food and Drug Administration panel voted 13-10 that the drug’s benefits outweigh its risks, including potential birth defects if used during pregnancy. 

The recommendation came after hours of debate about the drug’s modest benefits and potential safety issues. Experts backing the treatment stressed that it should not be used by anyone who is pregnant and called on the FDA to recommend extra precautions before the drug is prescribed, including pregnancy tests for women of child-bearing age. 

The vote specifically backed the drug for adults with mild-to-moderate COVID-19 who face the greatest risks, including older people and those with conditions like obesity and asthma. Most experts also said the drug shouldn’t be used in vaccinated patients, who weren’t part of the study and haven’t been shown to benefit. 

The FDA isn’t bound by the panel’s recommendation and is expected to make its own decision before year’s end. The pill is already authorized in the United Kingdom. 

The drug, molnupiravir, could provide a much-needed weapon against the virus as colder weather pushes case counts higher and U.S. officials brace for the arrival of the new omicron variant.

Merck hasn’t specifically tested its drug against the new variant but said it should have some potency based on its effectiveness against other strains of the coronavirus. 

But that uncertainty frustrated many panelists as they grappled with whether to back the treatment for millions of Americans. 

“With no data saying it works with new variants, I really think we need to be careful about saying that this is the way to go,” said Dr. David Hardy of Charles Drew University School of Medicine and Science, who ultimately voted to back the drug. 

Effectiveness, dangers

The panel’s narrow-but-positive recommendation came despite new data from Merck that paint a less compelling picture of the drug’s effectiveness than just a few weeks earlier. 

Last week, Merck said final study results showed molnupiravir reduced hospitalization and death by 30% among adults infected with the coronavirus, when compared with adults taking a placebo. That effect was significantly less than the 50% reduction it first announced based on incomplete results. 

That smaller-than-expected benefit amplified experts’ concerns about the drug’s toxicity for fetuses. 

FDA scientists told the panelists earlier Tuesday that company studies in rats showed the drug caused toxicity and birth defects when given at very high doses. Taken together, FDA staffers concluded the data “suggest that molnupiravir may cause fetal harm when administered to pregnant individuals.” 

FDA is weighing a blanket restriction against any use in pregnant women or allowing it in rare cases. Some panelists said the option should be left open for pregnant mothers who have high-risk COVID-19 and may have few other treatment options. 

Dr. Janet Cragan, who backed the drug, said that even with tight restrictions, some pregnant women would inevitably take the drug.

“I don’t think you can ethically tell a woman with COVID-19 that she can’t have the drug if she’s decided that’s what she needs,” a panel member and staffer with the Centers for Disease Control and Prevention. “I think the final decision has to come down to the individual woman and her provider.”

Merck’s drug uses a novel approach to fight COVID-19: It inserts tiny errors into the coronavirus’ genetic code to stop it from reproducing. That genetic effect has raised concerns that the drug could spur more virulent strains of the virus. But FDA regulators said Tuesday that risk is theoretical and seems unlikely. 

Pfizer drug

While Merck and its partner Ridgeback Biotherapeutics were the first to submit their COVID-19 pill to the FDA, rival drugmaker Pfizer is close behind with its own pill under review. 

Pfizer’s drug is part of a decades-old family of antiviral pills known as protease inhibitors, a standard treatment for HIV and hepatitis C. They work differently than Merck’s pill and haven’t been linked to the kind of mutation concerns raised with Merck’s drug. 

Pfizer said this week that its drug shouldn’t be affected by the omicron variant’s mutations. 

The U.S. government has agreed to purchase 10 million treatment courses of Pfizer’s drug, if it’s authorized. That’s more than three times the government’s purchase agreement with Merck for 3.1 million courses of molnupiravir. 

Both drugs require patients to take multiple pills, twice a day for five days. 

 

your ads here!

A Futuristic Tool Helps Viewers Access Black History

To make Black history more accessible, an Oakland, California man designed his own augmented reality app. Matt Dibble has the story.

your ads here!

1st French Omicron Case on Indian Ocean Island of Reunion

Japan and France confirmed their first cases of the new variant of the coronavirus on Tuesday as countries around the world scrambled to close their doors or find ways to limit its spread while scientists study how damaging it might be.

The World Health Organization has warned that the global risk from the omicron variant is “very high” based on early evidence, saying it could lead to surges with “severe consequences.”

French authorities on Tuesday confirmed the first case of the omicron variant in the French island territory of Reunion in the Indian Ocean. Patrick Mavingui, a microbiologist at the island’s research clinic for infectious diseases, said the person who has tested positive for the new variant is a 53-year-old man who had traveled to Mozambique and stopped in South Africa before returning to Reunion.

The man was placed in quarantine. He has “muscle pain and fatigue,” Mavingui said, according to public television Reunion 1ere.

Japan on Tuesday confirmed its first case in a visitor who recently arrived from Namibia, a day after banning all foreign visitors as an emergency precaution against the variant. A government spokesperson said the patient, a man in his 30s, tested positive upon arrival at Narita airport on Sunday and was isolated and is being treated at a hospital.

Cambodia barred entry to travelers from 10 African countries, citing the threat from the omicron variant. The move came just two weeks after Cambodia reopened its borders to fully vaccinated travelers on Nov. 15.

The new version was first identified days ago by researchers in South Africa.

WHO said there are “considerable uncertainties” about the omicron variant. But it said preliminary evidence raises the possibility that the variant has mutations that could help it both evade an immune-system response and boost its ability to spread from one person to another.

The WHO stressed that while scientists are hunting evidence to better understand this variant, countries should accelerate vaccinations as quickly as possible.

Despite the global worry, doctors in South Africa are reporting patients are suffering mostly mild symptoms so far. But they warn that it is early. Also, most of the new cases are in people in their 20s and 30s, who generally do not get as sick from COVID-19 as older patients. 

your ads here!

New Twitter CEO Steps From Behind the Scenes to High Profile 

Newly named Twitter CEO Parag Agrawal has emerged from behind the scenes to take over one of Silicon Valley’s highest-profile and politically volatile jobs. 

But his prior lack of name recognition, coupled with a solid technical background, appears to be what some big company backers were looking for to lead Twitter out of its current morass. 

A 37-year-old immigrant from India, Agrawal comes from outside the ranks of celebrity CEOs, which include the man he’s replacing, Jack Dorsey, Facebook’s Mark Zuckerberg or SpaceX and Tesla’s Elon Musk. Those brand-name company founders and leaders have often been in the news — and on Twitter — for exploits beyond the day-to-day running of their companies.

Having served as Twitter’s chief technology officer for the past four years, Agrawal’s appointment was seen by Wall Street as a choice of someone who will focus on ushering Twitter into what’s widely seen as the internet’s next era — the metaverse. 

Agrawal is a “‘safe’ pick who should be looked upon as favorably by investors,” wrote CFRA Research analyst Angelo Zino, who noted that Twitter shareholder Elliott Management Corp. had pressured Dorsey to step down. 

Elliott released a statement Monday saying Agrawal and new board chairman Bret Taylor were the “right leaders for Twitter at this pivotal moment for the company.” Taylor is president and chief operating officer of the business software company Salesforce. 

Agrawal joins a growing cadre of Indian American CEOs of large tech companies, including Sundar Pichai of Google parent Alphabet, Microsoft’s Satya Nadella and IBM’s Arvind Krishna. 

He joined San Francisco-based Twitter in 2011, when it had just 1,000 employees, and has been its chief technical officer since 2017. At the end of last year, the company had a workforce of 5,500. 

Agrawal previously worked at Microsoft, Yahoo and AT&T in research roles. At Twitter, he’s worked on machine learning, revenue and consumer engineering and helping with audience growth. He studied at Stanford and the Indian Institute of Technology, Bombay. 

While Twitter has high-profile users like politicians and celebrities and is a favorite of journalists, its user base lags far behind old rivals like Facebook and YouTube and newer ones like TikTok. It has just over 200 million daily active users, a common industry metric.

As CEO, Agrawal will have to step beyond the technical details and deal with the social and political issues Twitter and social media are struggling with. Those include misinformation, abuse and effects on mental health. 

Agrawal got a fast introduction to life as CEO of a high-profile company that’s one of the central platforms for political speech online. Conservatives quickly unearthed a tweet he sent in 2010 that read “If they are not gonna make a distinction between muslims and extremists, then why should I distinguish between white people and racists.”

As some Twitter users pointed out, the 11-year-old tweet was quoting a segment on “The Daily Show,” which was referencing the firing of Juan Williams, who made a comment about being nervous about Muslims on an airplane.

Twitter did not immediately respond to a message for comment on the tweet. 

your ads here!

Jury Seated in Trial of Former ‘Empire’ Actor Jussie Smollett

A jury was seated Monday to hear the case against Jussie Smollett, who says he was the victim of a racist and homophobic assault in downtown Chicago that authorities say was a hoax concocted and staged by the former “Empire” actor.

Two brothers, who worked with Smollett on the TV show, say he paid them $3,500 to pose as his attackers on a frigid night in January 2019. The men now stand at the center of the case that prosecutors will lay before jurors this week.

Smollett, who arrived at the courthouse in Chicago on Monday with his mother and other family members, is accused of lying to police about the alleged attack and has been charged with felony disorderly conduct. The Class 4 felony carries a prison sentence of up to three years, but experts have said it is likely that if Smollett is convicted, he would be placed on probation and perhaps ordered to perform community service. 

Twelve jurors plus three alternate jurors were sworn in and were expected to begin hearing opening arguments late Monday in a trial Judge James Linn said he expects to take about one week. During jury selection, Linn asked potential jurors if they have been the victim of a hate crime, if they have watched “Empire” or “TMZ,” a program and website about celebrities, or if they belong to any civil rights or pro-police organizations. Cameras are not allowed inside the courtroom, and the proceedings are not being livestreamed, unlike in other recent high-profile trials. 

Whether Smollett, who is Black and gay, will testify remains an open question. But the siblings, Abimbola and Olabinjo Osundairo, will take the witness stand where they are expected to repeat what they have told police officers and prosecutors: They carried out the attack at Smollett’s behest.

Jurors also may see surveillance video from more than four dozen cameras that police reviewed to trace the brothers’ movements before and after the reported attack, as well as a video showing the brothers purchasing a red hat, ski masks and gloves from a beauty supply shop hours earlier. 

Smollett’s attorneys have not spelled out how they will confront that evidence, and the lead attorney, Nenye Uche, declined to comment ahead of this week’s proceedings. But there are clues as to how they might do so during the trial. 

Buried in nearly 500 pages of Chicago Police Department reports is a statement from an area resident who says she saw a white man with “reddish brown hair” who appeared to be waiting for someone that night. 

She told a detective that when the man turned away from her, she “could see hanging out from underneath his jacket what appeared to be a rope.” 

Her comments could back up Smollett’s contention that his attackers draped a makeshift noose around his neck. Further, if she testified that the man was white, it would support Smollett’s statements — widely ridiculed because the brothers, who come from Nigeria, are Black — that he saw pale or white skin around the eyes of one of his masked attackers. 

Given there is so much evidence, including the brothers’ own statements that they participated in the attack, it is unlikely that Smollett’s attorneys will try to prove they did not take part. That could perhaps lead the defense to contend that Smollett was the victim of a very real attack at the hands of the brothers, perhaps with the help of others, who now are only implicating the actor so they won’t be charged, too.

The $3,500 check could be key, although Smollett says he wrote it to pay one of the brothers to work as his personal trainer. 

“I would assume the defense is going to zero in on that,” said Joe Lopez, a prominent defense attorney not involved with the case.

What they will almost certainly do is attack the brothers’ credibility, reminding jurors that they are not facing the same criminal charges as Smollett, despite admitting they took part in the staged attack. 

“Everything Smollett is responsible for, they are responsible for,” said David Erickson, a former state appellate judge who teaches at Chicago-Kent College of Law and is not involved in the case.

Finally, Smollett’s career could take center stage. Prosecutors could make the same point that then-Police Superintendent Eddie Johnson made when he announced Smollett’s arrest in 2019: Smollett thought the attack would win him more fame and a pay raise.

But Lopez said the defense attorneys might ask the jury the same question he asked himself.

“How would that help him with anything?” he asked. “He’s already a star.” 

 

your ads here!

Biden Urges Calm, Vaccination, in Face of Omicron Variant

U.S. President Joe Biden says a highly transmissible COVID-19 variant, dubbed omicron, is a cause for “concern, not panic” and defended his much-criticized decision to restrict travel from the southern African region, where it was first reported. VOA’s Anita Powell reports from the White House.

Produced by: Barry Unger

your ads here!

Twitter Founder and CEO Jack Dorsey Steps Down

Twitter founder and CEO Jack Dorsey is stepping down as the company’s leader.  

In a news release, Twitter said Dorsey would be replaced by Parag Agrawal, who has been the company’s chief technology officer since 2017. The move is effective immediately.  

“I’ve decided to leave Twitter because I believe the company is ready to move on from its founders. My trust in Parag as Twitter’s CEO is deep. His work over the past 10 years has been transformational. I’m deeply grateful for his skill, heart, and soul. It’s his time to lead,” Dorsey said in a statement.

Dorsey made his resignation official in a tweet Monday and attached a letter with an explanation of why he was leaving.  

“not sure anyone has heard but, I resigned from Twitter,” he wrote.

On Sunday, Dorsey tweeted “I love twitter.”

Dorsey, 45, founded the microblogging platform in 2006 and was CEO until 2008 when he was pushed aside only to return to the top spot in 2015.  

Last year, Elliott Management, a major stakeholder in the company, wanted Dorsey to choose between being CEO of Twitter or CEO of Square, a digital payment company he founded.  

Twitter’s stock rose on the news, but trading of the shares was suspended.

Some information in this report came from Reuters.

your ads here!

Merriam-Webster Chooses Vaccine as the 2021 Word of the Year

With an expanded definition to reflect the times, Merriam-Webster has declared an omnipresent truth as its 2021 word of the year: vaccine.

“This was a word that was extremely high in our data every single day in 2021,” Peter Sokolowski, Merriam-Webster’s editor-at-large, told The Associated Press ahead of Monday’s announcement. 

“It really represents two different stories. One is the science story, which is this remarkable speed with which the vaccines were developed. But there’s also the debates regarding policy, politics and political affiliation. It’s one word that carries these two huge stories,” he said.

The selection follows “vax” as word of the year from the folks who publish the Oxford English Dictionary. And it comes after Merriam-Webster chose “pandemic” as tops in lookups last year on its online site.

“The pandemic was the gun going off and now we have the aftereffects,” Sokolowski said.

At Merriam-Webster, lookups for “vaccine” increased 601% over 2020, when the first U.S. shot was administered in New York in December after quick development, and months of speculation and discussion over efficacy. The world’s first jab occurred earlier that month in the UK.

Compared to 2019, when there was little urgency or chatter about vaccines, Merriam-Webster logged an increase of 1,048% in lookups this year. Debates over inequitable distribution, vaccine mandates and boosters kept interest high, Sokolowski said. So did vaccine hesitancy and friction over vaccine passports.

The word “vaccine” wasn’t birthed in a day, or due to a single pandemic. The first known use stretches back to 1882 but references pop up earlier related to fluid from cowpox pustules used in inoculations, Sokolowski said. It was borrowed from the New Latin “vaccina,” which goes back to Latin’s feminine “vaccinus,” meaning “of or from a cow.”  

The Latin for cow is “vacca,” a word that might be akin to the Sanskrit “vasa,” according to Merriam-Webster. 

Inoculation, on the other hand, dates to 1714, in one sense referring to the act of injecting an “inoculum.”

Earlier this year, Merriam-Webster added to its online entry for “vaccine” to cover all the talk of mRNA vaccines, or messenger vaccines such as those for COVID-19 developed by Pfizer-BioNTech and Moderna. 

While other dictionary companies choose words of the year by committee, Merriam-Webster bases its selection on lookup data, paying close attention to spikes and, more recently, year-over-year increases in searches after weeding out evergreens. The company has been declaring a word of the year since 2008. Among its runners-up in the word biography of 2021:

INSURRECTION: Interest was driven by the deadly Jan. 6 siege on the U.S. Capitol. Arrests continue, as do congressional hearings over the attack by supporters of President Donald Trump. Some of Trump’s allies have resisted subpoenas, including Steve Bannon. Searches for the word increased by 61,000% over 2020, Sokolowksi said.

INFRASTRUCTURE: President Joe Biden was able to deliver what Trump often spoke of but never achieved: A bipartisan infrastructure bill signed into law. When Biden proposed help with broadband access, eldercare and preschool, conversation changed from not only roads and bridges but “figurative infrastructure,” Sokolowski said.

“Many people asked, what is infrastructure if it’s not made out of steel or concrete? Infrastructure, in Latin, means underneath the structure,” he said. 

PERSEVERANCE: It’s the name of NASA’s latest Mars rover. It landed Feb. 18, 2021. “Perseverance is the most sophisticated rover NASA has ever sent to the Red Planet, with a name that embodies NASA’s passion, and our nation’s capability, to take on and overcome challenges,” the space agency said.  

The name was thought up by Alexander Mather, a 14-year-old seventh-grader at Lake Braddock Secondary School in Burke, Virginia. He participated in an essay contest organized by NASA. He was one of 28,000 K-12 students to submit entries. 

NOMAD: The word had its moment with the 2020 release of the film “Nomadland.” It went on to win three Oscars in April 2021, including best picture, director (Chloé Zhao) and actress (Frances McDormand). Zhao became the first woman of color to win best director.  

The AP’s film writer Jake Coyle called the indie success “a plain-spoken meditation on solitude, grief and grit. He wrote that it “struck a chord in a pandemic-ravaged year. It made for an unlikely Oscar champ: A film about people who gravitate to the margins took center stage.”

Other words in Merriam-Webster’s Top 10: Cicada (we had an invasion), guardian (the Cleveland Indians became the Cleveland Guardians), meta (the lofty new name of Facebook’s parent company), cisgender (a gender identity that corresponds to one’s sex assigned at birth), woke (charged with politics and political correctness) and murraya (a tropical tree and the word that won the 2021 Scripps National Spelling Bee for 14-year-old Zaila Avant-garde).

your ads here!

Louis Vuitton Star Designer Virgil Abloh Dies After Battle With Cancer

Virgil Abloh, fashion’s highest profile Black designer and the creative mind behind Louis Vuitton’s menswear collections, died on Sunday of cancer, Vuitton’s owner LVMH said.

The French luxury goods giant said Abloh, 41, had been battling cancer privately for years.

“Virgil was not only a genius designer, a visionary, he was also a man with a beautiful soul and great wisdom,” LVMH’s billionaire boss Bernard Arnault said in a statement.

Abloh, a U.S. national who also worked as a DJ and visual artist, had been men’s artistic director for Vuitton, the world’s biggest luxury brand, since March 2018.

His arrival at LVMH marked the marriage between streetwear and high-end fashion, mixing sneakers and camouflage pants with tailored suits and evening gowns. His influences included graffiti art, hip hop and skateboard culture.

The style was embraced by the group as it sought to breathe new life into some labels and attract younger customers.

In July this year, LVMH expanded his role, giving him a mandate to launch new brands and partner with existing ones in a variety of sectors beyond fashion.

LVMH also bought a 60% stake in Abloh’s Off-White label, which it folded into the spirits-to-jewelry conglomerate.

“For over two years, Virgil valiantly battled a rare, aggressive form of cancer, cardiac angiosarcoma,” a message posted to his Instagram said. “He chose to endure his battle privately since his diagnosis in 2019, undergoing numerous challenging treatments, all while helming several significant institutions that span fashion, art, and culture.”

Abloh drew on messages of inclusivity and gender-fluidity to expand the Louis Vuitton label’s popularity, weaving themes of racial identity into his fashion shows with poetry performances and art installations.

With an eye to reaching Asian consumers grounded by the coronavirus pandemic, the designer sent his collections of colorful suits and utilitarian-flavored outerwear off to Shanghai last summer, when many labels canceled fashion shows.

“Virgil Abloh was the essence of modern creativity,” said an Instagram post by Alexandre Arnault, one of Bernard Arnault’s sons and executive vice president for product and communications at U.S. jeweler Tiffany, which LVMH bought this year.

your ads here!

WHO Calls for Renewed COVID Prevention Efforts Amid Omicron’s Spread

The World Health Organization says renewed efforts to prevent the spread of the coronavirus is needed as scientists scramble to determine the risks posed by the new omicron variant. Low vaccine rates combined with public fatigue over safety measures are putting more people in Africa at risk.

Experts say it’s no surprise a new variant of the coronavirus has been discovered.

Fewer than 8 percent of Africans are vaccinated against COVID-19, creating an environment for the illness to spread and mutate.

Dr. Mary Stephen is a technical officer for the World Health Organization’s Africa office. 

She said in the absence of vaccines, the public needs encouragement to uphold other measures to reduce the spread and save lives.

“We cannot be tired; we have to continue to make sure we are complying with wearing of our face masks, keeping our distance away, avoiding unnecessary mass gatherings, ensuring good hand hygiene, so that it’s another layer of protection in addition to the vaccination,” she said.

South African scientists detected the omicron variant last week.

Research is under way to determine how transmittable it is and its reaction to vaccines.

Amid uncertainty, Britain, the United States and European Union reacted by imposing travel bans to southern Africa.

Stephen, however, said the variant has already crossed continents and that halting flights to African countries that have long enforced testing for travelers is the wrong response. 

“The world should react to them with solidarity. The solution is not about banning travel but our ability to identify these cases, identify the potential risks, mitigate the risks, while we are still facilitating international travel because we have seen the devastating effects that COVID had on the economy,” she said.

Jeremiah Tshukudu is all too familiar with the economic toll of the pandemic.

The 45-year-old Uber driver said two of his cars were repossessed last year because he could no longer afford the payments during lockdown.

Tshukudu said he fears he’s about to take another financial hit with the new variant.

“I see us like losing close to let’s say 50% of what we’ve been earning recently. Relying on Uber, business was down, that means I wouldn’t be able to provide for the family,” he said.

Despite the pandemic’s impact on him, Tshukudu said he’s still hesitant about getting vaccinated.

With the threat of a new variant, experts are hoping people like him will reconsider.

Dr. Michelle Groome is with South Africa’s National Institute for Communicable Diseases. 

“Hopefully, you know, with some concern over coming fourth wave, hopefully, you know, those that were on the fence may actually go and vaccinate,” she said.

More than 3,200 people in South Africa tested positive for COVID-19 on Saturday, a marked increase from the day before.

The government is campaigning for more people to get vaccinated and even offering grocery vouchers to those who get their shot.

Government data show that at least 41 percent of South African adults have now been vaccinated.

your ads here!

Zimbabwe Says It’s Prepared for Omicron Variant

Zimbabwe’s government says the country is very prepared to handle the new COVID-19 variant – omicron – first reported in neighboring South Africa. The World Health Organization says a fourth wave of the pandemic is most likely to hit Africa.

Zimbabwe’s Vice President Constantino Chiwenga – who doubles as the country’s health minister – has asked the nation not to be concerned about omicron.

“The country should not panic because we are very prepared. The ramping up of our vaccination program in the past month has seen marked increase in the vaccination uptake. That is the prevention which we are going to have for our people if any other variant comes. At least when your body is protected it is much better than when you are found naked,” said the vice president.

Zimbabwe has fully inoculated about 2.8 million people since February, when it began its vaccination program to contain the COVID-19 pandemic. The government has a target of vaccinating at least 10 million Zimbabweans — or 60% of the population — by the end of the year, a figure which might be difficult to reach given the scarcity of resources and short time left.

Itai Rusike, head of the nonprofit Community Working Group on Health, said Zimbabweans should panic about the new variant – initially named B.1.1.529 – since the country shares porous borders with South Africa and Botswana.

“And this new variant is coming at a time when the festive season is upon us. A whole lot of Zimbabweans, they use undesignated entry points. That poses a serious health challenge as they would not be properly screened and monitored as they come back to the country. What we want to encourage the government of Zimbabwe, is for them to strengthen their surveillance and monitoring system especially the land borders and make sure that the screening and monitoring at the entry points is also strengthened,” said Rusike.

Meanwhile, Humphrey Karamagi, a medical officer at the World Health Organization Regional Office for Africa, said on the WHO Twitter account that a fourth wave of COVID-19 is likely to hit the continent.

“A fourth wave in Africa is almost a certainty, as long as we have these factors in play, which is new variants coming up and the fact that people can be reinfected. And also, if we are getting new population who may not have been exposed. We would then have subsequent waves. Vaccination helps a lot in terms of reducing the severity of the disease [and] also reducing the risk of infection. The vaccine is not a magic bullet. So the vaccine is to work together with the public health measures to reduce the potential and risks of subsequent waves,” said Karamagi.

The WHO says COVID-19 has infected about 6.1 million people in Africa and claimed 152,113 lives. The world health body also says more than 227 million vaccine doses have been administered in Africa.

your ads here!

Australian Government Vows to Unmask Online Trolls

Australia’s government said Sunday it will introduce legislation to unmask online trolls and hold social media giants like Facebook and Twitter responsible for identifying them.

Prime Minister Scott Morrison, whose conservative coalition government faces an election in the first half of 2022, said the law would protect Australians from online abuse and harassment.

“The online world should not be a wild west where bots and bigots and trolls and others can just anonymously go around and harm people and hurt people, harass them and bully them and sledge them,” Morrison told reporters.

“That is not what can happen in the real world, and there is no case for it to be able to be happening in the digital world.”

Attorney General Michaelia Cash said the legislation, reportedly to be introduced to parliament by early 2022, is needed to clarify that the social media platforms, and not the users, were responsible for defamatory comments by other people.

Confusion had been sown by a High Court ruling in September that found Australian media, as users managing their own pages on a social network, could be held liable for defamatory third-party comments posted on their pages, Cash said.

Under the planned Australian legislation, the social media companies themselves would be responsible for such defamatory content, not the users, she said.

It would also aim to stop people making defamatory comments without being identified, she said.

“You should not be able to use the cloak of online anonymity to spread your vile, defamatory comments,” the attorney general said.

The legislation would demand that social media platforms have a nominated entity based in Australia, she said.

The platforms could defend themselves from being sued as the publisher of defamatory comment only if they complied with the new legislation’s demands to have a complaints system in place that could provide the details of the person making the comment, if necessary, Cash said.

People would also be able to apply to the High Court for an “information disclosure order” demanding a social media service provide details “to unmask the troll,” the attorney general said.

In some cases, she said, the “troll” may be asked to take down the comment, which could end the matter if the other side is satisfied.

Australia’s opposition leader Anthony Albanese said he would support a safer online environment for everyone.

But he said the government had failed to propose action to stop the spread of misinformation on social media and accused some of the government’s own members of spreading misinformation about COVID and vaccinations.

your ads here!

COVID Variant Spreads to More Countries as World on Alert

The new potentially more contagious omicron variant of the coronavirus popped up in more European countries on Saturday, just days after being identified in South Africa, leaving governments around the world scrambling to stop the spread.

The U.K. on Saturday tightened its rules on mask-wearing and on testing of international arrivals after finding two cases. New cases were confirmed Saturday in Germany and Italy, with Belgium, Israel and Hong Kong also reporting that the variant has been found in travelers.

In the U.S., Dr. Anthony Fauci, the government’s top infectious diseases expert, said he would not be surprised if the omicron variant was already in the United States, too.

“We have not detected it yet, but when you have a virus that is showing this degree of transmissibility … it almost invariably is ultimately going to go essentially all over,” Fauci said on NBC television.

Because of fears that the new variant has the potential to be more resistant to the protection offered by vaccines, there are growing concerns around the world that the pandemic and associated lockdown restrictions will persist for far longer than hoped.

Nearly two years since the start of the pandemic that has claimed more than 5 million lives around the world, countries are on high alert. Many have already imposed travel restrictions on flights from southern Africa as they seek to buy time to assess whether the omicron variant is more transmissible than the current dominant delta variant.

In Britain, Prime Minister Boris Johnson said it was necessary to take “targeted and precautionary measures” after two people tested positive for the new variant in England.

“Right now this is the responsible course of action to slow down the seeding and the spread of this new variant and to maximize our defenses,” he told a news conference.

Among the measures announced, Johnson said anyone arriving in England must take a PCR test for COVID-19 on the second day after their arrival and self-isolate until they provide a negative test. And if someone tests positive for the omicron variant, then he said their close contacts will have to self-isolate for 10 days regardless of their vaccination status — currently close contacts are exempt from quarantine rules if they are fully vaccinated.

He also said mask-wearing in shops and on public transport will be required and said the independent group of scientists that advises the British government on the rollout of coronavirus vaccines has been asked to accelerate the vaccination program. This could involve widening the booster program to younger age groups, reducing the time period between a second dose and a booster and allowing older children to get a second dose.

“From today we’re going to boost the booster campaign,” he said.

 

Britain’s Department of Health said the two cases found in the U.K. were linked and involved travel from southern Africa. One of the two new cases was in the southeastern English town of Brentwood, while the other was in the central city of Nottingham. The two confirmed cases are self-isolating with their households while contact tracing and targeted testing takes place.

The British government also added four more countries — Angola, Malawi, Mozambique and Zambia — to the country’s travel red list from Sunday. Six others — Botswana, Eswatini (formerly Swaziland), Lesotho, Namibia, South Africa and Zimbabwe — were added Friday. That means anyone permitted to arrive from those destinations will have to quarantine.

Many countries have slapped restrictions on various southern African countries over the past couple of days, including Australia, Brazil, Canada, the European Union, Iran, Japan, New Zealand, Thailand and the United States, in response to warnings over the transmissibility of the new variant. This goes against the advice of the World Health Organization, which has warned against any overreaction before the variant was thoroughly studied.

Despite the banning of flights, there are mounting concerns that the variant has already been widely seeded around the world.

Italy and Germany were the latest to report confirmed cases of the omicron variant.

An Italian who had traveled to Mozambique on business landed in Rome on Nov. 11 and returned to his home near Naples. He and five family members, including two school-age children, have since tested positive, the Italian news agency LaPresse said. All are isolating in the Naples suburb of Caserta in good condition with light symptoms.

The variant was confirmed by Sacco hospital in Milan, and Italy’s National Health Institute said the man had received two doses of the vaccine. Italy’s health ministry is urging all regions to increase tracing of the virus and sequencing to detect cases of the new variant first identified in South Africa.

In Germany, the Max von Pettenkofer Institute, a Munich-based microbiology center, said the omicron variant was confirmed in two travelers who arrived on a flight from South Africa on Nov. 24. The head of the institute, Oliver Keppler, said that genome sequencing has yet to be completed, but it is “proven without doubt that it is this variant,” German news agency dpa reported.

 

The Dutch public health institute said the omicron variant was “probably found in a number of the tested persons” who were isolated after arriving Friday in Amsterdam on two flights from South Africa. The institute said in a statement that further sequencing analysis is underway to determine for sure that it is the new variant. The results were expected Sunday. A total of 61 people were tested.

Israel said it detected the new strain in a traveler who had returned from Malawi and was tracing 800 travelers who returned recently from southern African countries. And Australia said early Sunday its scientists were working to determine whether two people who tested positive for COVID after arriving from southern Africa are infected with the omicron variant.

The variant’s swift spread among young people in South Africa has alarmed health professionals even though there was no immediate indication whether the variant causes more severe disease.

Several pharmaceutical firms, including AstraZeneca, Moderna, Novavax and Pfizer, said they have plans in place to adapt their vaccines in light of the emergence of omicron. Pfizer and its partner BioNTech said they expect to be able to tweak their vaccine in around 100 days.

Professor Andrew Pollard, the director of the Oxford Vaccine Group, which developed the AstraZeneca vaccine, expressed cautious optimism that existing vaccines could be effective at preventing serious disease from the omicron variant, noting that most of the mutations appear to be in similar regions as those in other variants.

“At least from a speculative point of view we have some optimism that the vaccine should still work against a new variant for serious disease, but really we need to wait several weeks to have that confirmed,” he told BBC radio.

Some experts said the variant’s emergence illustrated how rich countries’ hoarding of vaccines threatens to prolong the pandemic.

Fewer than 6% of people in Africa have been fully immunized against COVID-19, and millions of health workers and vulnerable populations have yet to receive a single dose. Those conditions can speed up spread of the virus, offering more opportunities for it to evolve into a dangerous variant.

“One of the key factors to emergence of variants may well be low vaccination rates in parts of the world, and the WHO warning that none of us is safe until all of us are safe and should be heeded,” said Peter Openshaw, a professor of experimental medicine at Imperial College London.

U.S. Secretary of State Antony Blinken spoke Saturday with his South African counterpart, Naledi Pandor, and they stressed the importance of working together to help African nations vaccinate their populations, the State Department said in a statement. It said Blinken praised South Africa’s scientists for quickly identifying the omicron variant and the government for its transparency in sharing this information, “which should serve as a model for the world.” 

 

your ads here!

US Praises South Africa’s Quick Detection, Sharing Variant Information

The United States praised South Africa on Saturday for quickly identifying the latest coronavirus variant, omicron, and sharing this information with the world.

Secretary of State Antony Blinken spoke with South Africa’s international relations and cooperation minister, Naledi Pandor, and they discussed cooperation on vaccinating people in Africa against COVID-19, the State Department said in a statement.

“Secretary Blinken specifically praised South Africa’s scientists for the quick identification of the omicron variant and South Africa’s government for its transparency in sharing this information, which should serve as a model for the world,” the statement said.

First detected in South Africa, the omicron variant of the coronavirus that causes COVID-19, was deemed by the World Health Organization a “variant of concern” on Friday.

Earlier Saturday, Pandor’s office issued a statement saying that the country is being punished for detecting the new variant as more countries rush to enact travel bans and restrictions.

By Saturday, more than a dozen countries had announced temporary travel restrictions on South Africa and other countries in the region after cases were reported in Europe and the Middle East. 

your ads here!

Hong Kong Protest Film Wins at Chinese-Language ‘Oscars’

A documentary about pro-democracy protests in Hong Kong won a high-profile award Saturday in Taiwan at the Golden Horse Awards, the Chinese-speaking world’s version of the Oscars.

Kiwi Chow’s “Revolution of Our Times” was named best documentary, prompting a long round of applause and shouts of support for Hong Kong from audience members at the glitzy event in Taipei.

Chow, who sent a pre-recorded message from Hong Kong expressing thanks for the award, dedicated the film to Hong Kong’s people, saying he hoped it would bring them some comfort.

“I cried a lot when I produced this film; several times I comforted myself with this film, to express my anger, hatred, to face my fear and trauma,” he said, his voice cracking with emotion.

Native Hongkonger Chow’s film follows several protesters and documents clashes with police during the 2019 demonstrations, and he has previously told Reuters he hoped the documentary would help the pro-democracy movement live on.

It was shown at this year’s Cannes Film Festival in a surprise addition to the lineup. China introduced a sweeping national security law for Hong Kong over a year ago to crack down on what it deems subversion, secessionism, terrorism and collusion with foreign forces.

Since then, cinemas, universities and art galleries have canceled screenings or exhibitions of protest-related works. The protesters have won broad support and sympathy in democratically-ruled Taiwan.

China, which claims Taiwan as its own territory, in 2019 blocked the country’s movie industry from participating in the Golden Horse Awards, which were founded in 1962 and take place annually in Taiwan.

Beijing’s move followed uproar in 2018 in China and among Chinese stars at the awards ceremony after Taiwanese director Fu Yue made comments in support of Taiwan’s formal independence, a red line for Beijing.

your ads here!

FDA: Merck COVID pill effective, experts will review safety

Federal health regulators say an experimental COVID-19 pill from Merck is effective against the virus, but they will seek input from outside experts on risks of birth defects and other potential problems during pregnancy.

The Food and Drug Administration posted its analysis of the pill ahead of a public meeting next week where academic and other experts will weigh in on its safety and effectiveness. The agency isn’t required to follow the group’s advice.

The FDA scientists said their review identified several potential risks, including possible toxicity to developing fetuses and birth defects that were identified in studies of the pill in animals. 

Given those risks the FDA will ask its advisers next Tuesday whether the drug should never be given during pregnancy or whether it could be made available in certain cases.  

Under that scenario, the FDA said the drug would carry warnings about risks during pregnancy, but doctors would still have the option to prescribe it in certain cases where its benefits could outweigh its risks for patients.

Given the safety concerns, FDA said Merck agreed the drug would not be used in children.

Other side effects were mild and rare, with about 2% of patients experiencing diarrhea.

Regulators also noted that Merck collected far less safety data overall on its drug than was gathered for other COVID-19 therapies.

“While the clinical safety data base was small, there were no major safety concerns identified,” FDA reviewers concluded.

Additionally, the FDA flagged a concern that Merck’s drug led to small changes in the coronavirus’ signature spike protein, which it uses to penetrate human cells. 

Theoretically, FDA cautioned, those changes could lead to dangerous new variants.

FDA will ask its independent advisers to discuss all those issues and then vote on whether the drug’s overall benefits outweigh its risks.

All COVID-19 drugs currently authorized by the FDA require an injection or IV and can only be given by health professionals. If authorized, Merck’s drug would be the first that U.S. patients could take at home to ease symptoms and speed recovery. It is already authorized for emergency use in the U.K. 

The meeting marks the first time regulators have publicly reviewed a new drug for COVID-19, reflecting the intense interest and scrutiny of a pill that could be soon used by millions of Americans.

your ads here!

France Says it is Willing to Discuss Autonomy for Guadeloupe

France is willing to discuss autonomy for the French Caribbean territory of Guadeloupe if it is in the interests of the people who live there, government minister Sebastien Lecornu said.

Guadeloupe and the nearby French island of Martinique have seen several days of protests against COVID-19 measures that have spilled over into violence.

Lecornu, the minister for France’s overseas territories, said in a YouTube video issued late on Friday that certain elected officials in Guadeloupe had raised the question of autonomy, changing its status as an overseas region.

“The government is ready to talk about this. There are no bad debates, as long as those debates serve to resolve the real everyday problems of people in Guadeloupe,” he said.

That was one of a series of initiatives he said the government in Paris would be taking in Guadeloupe, including improving healthcare, infrastructure projects, and a scheme to create jobs for young people.

The French government this week announced that it would be postponing a requirement that public sector workers in Guadeloupe and Martinique get a COVID-19 vaccination.

That had sparked protests, fanning long-standing grievances over living standards and the relationship with Paris.

In Guadeloupe there is a historic mistrust of the French government’s handling of health crises after many people were exposed to toxic pesticides used in banana plantations in the 1970s.

 

 

your ads here!

India’s Serum Institute Resumes Vaccine Exports to COVAX Vaccine Sharing Program

The world’s largest vaccine maker, the Serum Institute of India has resumed exports of coronavirus vaccines to COVAX the partnership that is distributing vaccines to developing countries. The resumption of exports comes at a critical time when a new variant found in South Africa is causing concern around the world.

India suspended exports of vaccines in March this year following a severe surge in infections during the second wave of the COVID-19 pandemic as it used its stocks to ramp up its domestic inoculation program.

The first shipments went out Friday.

“This will go a long way in restoring vaccine supply equality in the world,” Serum Institute chief executive Adar Poonawalla said on Twitter.

The company said in a press statement that said that it expects the supply of vaccines to COVAX to increase substantially in early 2022. The Serum Institute of India was expected to be one of the main suppliers to the vaccine sharing facility which was created to ensure global equitable access to COVID-19 vaccines after the outbreak of the pandemic.

The Serum Institute linked the resumption of exports to surpassing its target of producing 1 billion doses of the AstraZeneca vaccine by the end of this year – it has produced 1.25 billion doses so far.

Gavi, the Vaccine Alliance, which leads the COVAX program along with the World Health Organization, called the restart of exports from India an important development “as it enters its busiest period yet for shipping vaccines to participating economies.”

The export curbs by India were a huge setback to efforts by COVAX, which had been relying on supplies of the affordable and easy to store AstraZeneca vaccine from India’s Serum Institute to distribute to low-income countries. The vaccine is called Covishield in India.

“While COVAX’s portfolio is now much more diversified than it was earlier this year when we received our first SII deliveries, COVISHIELD remains an important product which has the potential to help us protect hundreds of millions of people in the months ahead,” according to Seth Berkley, chief executive of GAVI, the Vaccine Alliance.

India has allowed exports to resume as its vaccination program makes substantial progress and vaccine supplies improve – about 80% of the country has received one dose and about 40% is fully vaccinated. Cases of coronavirus have also reduced dramatically – on Friday, India reported about 9,000 cases.

However, a new variant found in South Africa, dubbed omicron, is causing widespread concern and has prompted experts in India to caution against complacency. Designated a variant of concern by the World Health Organization, omicron has already been found in Belgium, Botswana, Israel and Hong Kong and has prompted several countries, including the United States and Britain to impose travel curbs.

India has said it is scaling up screening of passengers from overseas. At a meeting held Saturday to review the pandemic, Prime Minister Narendra Modi asked officials to review plans to ease international travel restrictions.

“In light of the new variant, we remain vigilant with a focus on containment and ensuring increased second dose coverage,” he tweeted. 

your ads here!

Tourists Rush to South Africa Airport After Travel Bans Issued

Anxious-looking travelers thronged Johannesburg international airport and stood in long queues on Friday, desperate to squeeze onto the last flights to countries that had just shut their doors to South Africa.

Many cut short their holidays, rushing back from safaris and vineyards when Britain announced late Thursday night that all flights from South Africa and its neighbors would be banned the following day.

A flurry of nations — including the United States, Canada and several European countries — have followed suit, concerned about the discovery of a new coronavirus variant, renamed omicron, with several mutations fueling an infection resurgence in South Africa.

United Kingdom citizen Toby Reid, a 24-year-old trader in London, was camping on Cape Town’s Table Mountain with his girlfriend when the ban was announced.

“At about 5:30 a.m., we got up to see if we could catch the sunrise, and at six in the morning, we found out that there was still a possibility to get back,” he told AFP while standing in line for check-in at the Johannesburg airport just hours later.

The couple managed to grab the last two seats on an evening flight to Frankfurt, Germany.

Others who were not so lucky discussed options at ticket counters, eyes widening at proposed prices and convoluted itineraries.

“There should have been more notice,” muttered Christian Good, 50, returning to Devon, England, via Frankfurt with his husband after a beach holiday.

By chance, the pair had originally planned to return on that flight, meaning they would arrive home before mandatory hotel quarantine begins on Sunday — a requirement for citizens returning from “red list” countries.

“It’s ridiculous. We will always be having new variants,” his husband, David, exclaimed, passports in hand.

“South Africa found it, but it’s probably all over the world already,” he told AFP.

The variant has so far been detected in Belgium, Botswana, Israel and Hong Kong.

‘Tired of this’

At the airport, red “canceled” signs flashed next to London-bound flights listed on the departures board.

Other destinations were still in limbo.

A KLM flight to Amsterdam was delayed by several hours after passengers were suddenly compelled to produce negative COVID-19 results.

Rapid PCR tests were offered at the airport, with results guaranteed in two hours, but at a cost of $86, compared with the standard fee of around $52 for results delivered in roughly 12 hours.

An AFP correspondent observed Some African passport holders being told they would not be allowed to fly to Europe.

Earlier, travelers milled around a closed Air France check-in desk, waiting to find out whether an evening flight to Paris would take off as scheduled, just hours after France announced its own ban.

Among them were U.K. citizen Ruth Brown, 25, who lives in South Africa and had planned to return home for the first time since 2019 next week.

Britain kept South Africa on its red list until early October, meaning many of its citizens have been unable to travel back since the pandemic started because of the costly hotel quarantine.

They had only a few weeks of leeway before the status was revoked.

“We are tired of this situation,” said Brown, who spent the morning on the phone trying to change her flight.

“Apparently (this one) is full, but we are trying to see if we can still get seats,” she sighed.

Further down the line, Elke Hahn cradled a toddler.

She had traveled to South Africa with her partner to adopt the child and was desperate to get back to their home in Austria.

The child’s paperwork was only valid for a specific flight route that had since been changed.

“We will have to get another flight, but I don’t know how that will work,” she said. 

your ads here!

Fauci: US Must Study Data Before Deciding on Travel Ban Over New COVID Variant

Top U.S. infectious disease official Anthony Fauci said Friday that a ban on flights from southern Africa was a possibility and the United States was rushing to gather data on the new COVID-19 variant. 

 

No decision to halt flights had yet been made, he said. The Wall Street Journal, citing people familiar with the matter, said White House officials were discussing potential travel restrictions on southern African countries. Those officials were expected to meet with agency officials Friday afternoon to make a recommendation, the newspaper said, without specifying which agency. 

 

The White House referred to Fauci’s earlier comments when asked about the report and declined further comment. Global authorities have reacted with alarm to the new variant, detected in South Africa, with the European Union and Britain among those tightening border controls as scientists seek to find out if the mutation is vaccine-resistant. 

 

The World Health Organization (WHO), however, has cautioned against hasty measures and South Africa said a British ban on flights seemed rushed. 

 

“There is always the possibility of doing what the UK has done, namely block travel from South Africa and related countries,” Fauci said in an interview on CNN. 

 

“That’s certainly something you think about and get prepared to do. You’re prepared to do everything you need to protect the American public. But you want to make sure there’s a basis for doing that,” he said. 

 

“Obviously as soon as we find out more information we’ll make a decision as quickly as we possibly can.”

 

Fauci said U.S. scientists would speak with South African counterparts Friday about the new variant, called B.1.1.529, which has raised concern about its transmissibility and whether it might evade immune responses. 

 

He added there was no indication the new variant was already in the United States. 

 

 

 

your ads here!

New COVID-19 Variant Detected in South Africa

South African scientists are scrambling to determine how quickly a newly discovered variant of the coronavirus can spread and if it is resistant to vaccines.  The new strain has led Britain to reimpose flight bans on six southern African countries, which could deal another heavy blow to their economies. 

Coronavirus cases are once again on the rise in South Africa. 

Amid the spike, several mutations of a new variant called the B 1.1.529 have been detected in the country, Botswana and Hong Kong. 

It has sparked concern it could compete with the previously dominant delta variant and trigger another wave of the pandemic.

Dr. Michelle Groome is with South Africa’s National Institute for Communicable Diseases.

“There’s the potential that this could be more transmissible and that this, there is potential immune escape, but we don’t know yet,” said Groome. “We are busy conducting some laboratory tests, obviously, we can have a look at how, you know, this new variant reacts both to, you know, serum from people who have been infected previously, as well as vaccinated, which will give us a better idea of the potential immune escape.”  

The uncertainty has prompted travel restrictions. 

Britain added six African countries to its so-called red list today, requiring quarantine for incoming travelers and temporarily banning flights.

The European Union also is looking at halting air travel from southern Africa. 

The South African government has called the decisions “rushed” and raised concerns about the impact on business. 

The CEO of South Africa’s inbound tourism association, David Frost, says the effects will be devastating on the sector.  

“We got off the red list in in October and it was sorely needed. We’ve been shut down for over 18 months,” said Frost. “You know, the industry really is on its knees. The impact of this is absolutely dire to livelihoods, to families.”

While social distancing and mask use can help combat the virus, Dr. Groome also questions the efficacy of travel bans.  

“We haven’t been able to contain the spread initially of the of the original virus, and all subsequent variants have spread globally, you know,” said Groome. “I think there’s limited value in terms of these restrictions.”  

Instead, she says vaccinating more of the population would help prevent the most severe cases and deaths.

Roughly 35 percent of the South Africa’s adult population is vaccinated, a figure far below targets of 70 percent. 

Figures are even lower across much of the continent.

Experts have warned vaccine inequality would create a breeding ground for the virus to mutate. 

Astrid Haas is an independent urban economist in Kampala, Uganda.  

“In Europe now and in North America, in particular, they’re talking about booster shots and third vaccines, whereas we know now from the WHO, that less than 10% of African countries are going to even meet their vaccine target for this year. …Just a very sad manifestation of the global vaccine inequity,” said Haas.

In the absence of vaccinations, lockdowns may be on the horizon. 

Such measures already have taken a harsh economic toll across southern Africa. 

Haas says the halt to retail and other services has made it hard for many people to survive.  

“Particularly with respect to the urban poor is that a lot of income is used to purchase food, or a high proportion of income is used to purchase food, and when they are not able to make income, then that affects food security as well,” said Haas.

South African President Cyril Ramaphosa is convening the country’s coronavirus council this weekend in response to the new variant. 

The government says it will announce any new measures in coming days. 

your ads here!

Cases Soar but Swiss Reject Lockdown as COVID Law Vote Looms

Like many others in Europe, Switzerland is facing a steep rise in coronavirus cases. But its federal government, unlike others, hasn’t responded with new restrictive measures. Analysts say it doesn’t want to stir up more opposition to its anti-COVID-19 policies, which face a crucial test at the ballot box this weekend as critics have grown increasingly loud.

On Sunday, as part of the country’s regular referendums, Swiss voters will cast ballots about the so-called “COVID-19 law” that has unlocked billions of Swiss francs (dollars) in aid for workers and businesses hit by the pandemic. The law has also imposed the use of a special COVID certificate that lets only people who have been vaccinated, recovered, or tested negative attend public events and gatherings.

If the Swiss give a thumbs-up, the government may well ratchet up its anti-COVID efforts.

The vote offers a relatively rare bellwether of public opinion specifically on the issue of government policy to fight the coronavirus in Europe, the global epicenter of the pandemic. The continent enjoys relatively high rates of vaccination compared with countries in Africa, Asia and the Middle East, but has been nearly alone in facing a surge in cases in recent weeks.

Polls suggest a solid majority of Swiss will approve the measure, which is already in effect and the rejection of which would end the restrictions — as well as the payouts. But in recent weeks, opponents have raised heaps of cash for their campaign and drawn support from abroad, including a visit from American anti-vaccination campaigner Robert F. Kennedy Jr. to a rally in the capital, Bern, this month.

Swiss weekly NZZ am Sonntag reported that campaigners have sent hundreds of petitions to government offices around the country alleging that the language in the referendum question is vague and makes no mention of the “COVID certificate” that affords access to places like restaurants and sporting events.

On Tuesday, Swiss health authorities warned of a rising “fifth wave” in the rich Alpine country, where vaccination rates are roughly in line with those in hard-hit Austria and Germany — at about two-thirds of the population. Infection rates have soared in recent weeks. The seven-day average case count in Switzerland shot up to more than 5,200 per day from mid-October to mid-November, a more than five-fold increase — with an upward curve like those in neighboring Germany and Austria.

Austria has responded with a much-ballyhooed lockdown, and Germany — which is forming a new government as Chancellor Angela Merkel’s tenure nears its end — has taken some steps like requiring workers to provide their employers with proof of vaccination, recovery or a negative test set to take effect next week.

The Swiss Federal Council, the seven-member executive branch, went out of its way on Wednesday to say: “It’s not the time to decree a tightening of measures nationwide,” while opting for a region-by-region approach and calling on citizens to act responsibly through mask-wearing, physical distancing, and proper airing of indoor areas.

That’s even though the council admitted in a statement that cases — particularly among the young — are rising and “the number of daily infections has reached a record for the year and the exponential rise is continuing.” Hospitalizations — notably among the elderly — are rising too, it said, but not as fast.

Swiss Health Minister Alain Berset has insisted his government hasn’t tightened restrictions because COVID-19 patients still make up only a small percentage of people in intensive-care units.

“But we also know that the number of hospitalizations lags behind the number of infections,” said Pascal Sciarini, a political scientist at the University of Geneva. “One can imagine that if Switzerland didn’t have this particular event — the vote on Sunday — we’d already be preparing (the) next steps.”

The Swiss council may simply be holding its breath through the weekend, he suggested.

“I wouldn’t be surprised if as early as next week, the tone changes,” Scarini said. “It’s starting to budge … the Federal Council is surely going to wait until after the referendum.” 

 

your ads here!